MS-2300

A 36-year-old man has contracted an RNA flavivirus due to his intravenous drug use. He has been given a medication ‘X’ that is a guanine purine nucleoside analogue. This medication obstructs an enzyme in the de novo purine synthesis pathway, which impedes the capping of viral mRNA and its production.

What is the probable identity of drug ‘X’?